131 related articles for article (PubMed ID: 37727934)
1. Subcutaneous Leiomyosarcoma: An Aggressive Malignancy Portending a Significant Risk of Metastasis and Death.
Bresler SC; Gosnell HL; Ko JS; Angeles CV; Ronen S; Billings SD; Patel RM
Am J Surg Pathol; 2023 Dec; 47(12):1417-1424. PubMed ID: 37727934
[TBL] [Abstract][Full Text] [Related]
2. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".
Kraft S; Fletcher CD
Am J Surg Pathol; 2011 Apr; 35(4):599-607. PubMed ID: 21358302
[TBL] [Abstract][Full Text] [Related]
3. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
4. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes.
Winchester DS; Hocker TL; Brewer JD; Baum CL; Hochwalt PC; Arpey CJ; Otley CC; Roenigk RK
J Am Acad Dermatol; 2014 Nov; 71(5):919-25. PubMed ID: 25174541
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors.
Aneiros-Fernandez J; Antonio Retamero J; Husein-Elahmed H; Ovalle F; Aneiros-Cachaza J
Eur J Dermatol; 2016; 26(1):9-12. PubMed ID: 26678649
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous leiomyosarcoma: dermal and subcutaneous.
Wong GN; Webb A; Gyorki D; McCormack C; Tran P; Ngan SY; Slavin J; Henderson MA
Australas J Dermatol; 2020 Aug; 61(3):243-249. PubMed ID: 32537765
[TBL] [Abstract][Full Text] [Related]
7. Management of superficial leiomyosarcoma: a retrospective study of 10 cases.
Tsutsumida A; Yoshida T; Yamamoto Y; Itoh T; Minakawa H; Sugihara T
Plast Reconstr Surg; 2005 Jul; 116(1):8-12. PubMed ID: 15988239
[TBL] [Abstract][Full Text] [Related]
8. Leiomyosarcoma of the urinary bladder: a clinicopathological study of 34 cases.
Lindberg MR; Fisher C; Thway K; Cao D; Cheville JC; Folpe AL
J Clin Pathol; 2010 Aug; 63(8):708-13. PubMed ID: 20702472
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases.
Laskin WB; Fanburg-Smith JC; Burke AP; Kraszewska E; Fetsch JF; Miettinen M
Am J Surg Pathol; 2010 Jun; 34(6):873-81. PubMed ID: 20463568
[TBL] [Abstract][Full Text] [Related]
10. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous leiomyosarcoma. A histological and immunohistochemical study of 9 cases, with ultrastructural correlation.
Swanson PE; Stanley MW; Scheithauer BW; Wick MR
J Cutan Pathol; 1988 Jun; 15(3):129-41. PubMed ID: 3294254
[TBL] [Abstract][Full Text] [Related]
12. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
[TBL] [Abstract][Full Text] [Related]
13. Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific Mortality.
Carr MJ; Sun J; Adams WA; Dugan MM; Naqvi SMH; Kim Y; Messina JL; Gonzalez RJ; Zager JS; Mullinax JE
Cancer Control; 2023; 30():10732748231206957. PubMed ID: 37876208
[TBL] [Abstract][Full Text] [Related]
14. Leiomyosarcoma of the skin: review of the literature with an emphasis on prognosis and management.
Kazlouskaya V; Lai YC; Khachemoune A
Int J Dermatol; 2020 Feb; 59(2):165-172. PubMed ID: 31729020
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous leiomyosarcoma: a retrospective review of 45 cases.
Khan S; Asher R; Perkins W; Matin RN
Clin Exp Dermatol; 2023 Dec; 49(1):2-8. PubMed ID: 37595134
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases.
Massi D; Franchi A; Alos L; Cook M; Di Palma S; Enguita AB; Ferrara G; Kazakov DV; Mentzel T; Michal M; Panelos J; Rodriguez-Peralto JL; Santucci M; Tragni G; Zioga A; Dei Tos AP
Histopathology; 2010 Jan; 56(2):251-62. PubMed ID: 20102404
[TBL] [Abstract][Full Text] [Related]
17. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
18. S1-guideline cutaneous and subcutaneous leiomyosarcoma.
Helbig D; Dippel E; Erdmann M; Frisman A; Kage P; Leiter U; Mentzel T; Seidel C; Weishaupt C; Ziemer M; Ugurel S
J Dtsch Dermatol Ges; 2023 May; 21(5):555-563. PubMed ID: 36999582
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of superficial leiomyosarcoma.
Wellings EP; Tibbo ME; Rose PS; Folpe AL; Houdek MT
J Surg Oncol; 2021 Jan; 123(1):127-132. PubMed ID: 33063336
[TBL] [Abstract][Full Text] [Related]
20. Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases.
Farshid G; Pradhan M; Goldblum J; Weiss SW
Am J Surg Pathol; 2002 Jan; 26(1):14-24. PubMed ID: 11756765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
